Trial Profile
Nedaplatin (injection with Nedaplatin Combined with gemcitabine and cisplatin combined with gemcitabine in the first-line treatment of advanced lung carcinoma randomized controlled multicenter clinical study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2016
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Nedaplatin (Primary) ; Cisplatin
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 15 Jul 2016 New trial record